Sat 28 Nov 2009 | 13:02 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. (ALNY.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View ALNY on other exchanges
As of  27 Nov 2009
16.78USD
Price Change
-0.29
Percent Change
-1.70%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Allen, Patricia 47 2006 Vice President - Finance, Treasurer
Schmidt, John 58 2008 Senior Vice President, Chief Scientific Officer
Vaishnaw, Akshay -- 2009 Senior Vice President - Clinical Research
Greene, Barry 45 2007 President, Chief Operating Officer
Schimmel, Paul 68 2002 Director
Sharp, Phillip 65 2002 Director
Starr, Kevin 46 2003 Director
Vincent, James 69 2005 Director
Sato, Vicki 60 2005 Director
Dzau, Victor 63 2007 Director
Scolnick, Edward 68 2008 Director
Maraganore, John 46 2007 Chief Executive Officer, Director
Clarke, John 55 2002 Chairman of the Board